Simone Albisinni

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 226 publications

The PROTEUS trial: envisioning the future of perioperative therapy and radical prostatectomy for high-risk prostate cancer. Official position of the Italian Society of Urology (SIU).

The PROTEUS trial: envisioning the future of perioperative therapy and radical prostatectomy for high-risk prostate cancer. Official position of the Italian Society of Urology (SIU).

Journal: Minerva urology and nephrology

Published: August 03, 2026

Reply to Bayraktar and Işler.

Reply to Bayraktar and Işler.

Journal: BJU international

Published: July 30, 2026

The old standard still holds up: reading CREST, POTOMAC, and ALBAN in BCG-naive high-risk non-muscle-invasive bladder cancer.

The old standard still holds up: reading CREST, POTOMAC, and ALBAN in BCG-naive high-risk non-muscle-invasive bladder cancer.

Journal: Minerva urology and nephrology

Published: June 23, 2026

Rethinking first-line therapy in overactive bladder: is it time for a paradigm shift?

Rethinking first-line therapy in overactive bladder: is it time for a paradigm shift?

Journal: Minerva urology and nephrology

Published: June 19, 2026

Beyond the Scalpel: how the PROTEUS trial redefines the role of the radical prostatectomy.

Beyond the Scalpel: how the PROTEUS trial redefines the role of the radical prostatectomy.

Journal: Prostate cancer and prostatic diseases

Published: June 11, 2026

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Journal: Future oncology (London, England)

Published: April 27, 2026

Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.

Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.

Journal: Urologic oncology

Published: April 20, 2026

Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.

Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.

Journal: ESMO open

Published: April 13, 2026

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

Journal: World journal of urology

Published: April 12, 2026

Impact of audit and feedback on transurethral resection of bladder tumour quality: a monocentric post-completion evaluation of the RESECT trial.

Impact of audit and feedback on transurethral resection of bladder tumour quality: a monocentric post-completion evaluation of the RESECT trial.

Journal: BJU international

Published: April 01, 2026

Discordant Response in Pelvic Lymph Nodes and Cystectomy Specimens After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.

Discordant Response in Pelvic Lymph Nodes and Cystectomy Specimens After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.

Journal: European urology focus

Published: March 24, 2026

Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Journal: BJU international

Published: March 20, 2026

Showing 1-12 of 226

Last Updated: 09/26/2026